Hennion & Walsh Asset Management, Inc. - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 155 filers reported holding AMNEAL PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
Hennion & Walsh Asset Management, Inc. ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$73
-32.4%
52,339
-3.2%
0.00%
-42.9%
Q4 2022$108
-99.9%
54,070
-12.7%
0.01%
-12.5%
Q3 2022$125,000
-39.6%
61,940
-4.9%
0.01%
-38.5%
Q2 2022$207,000
-24.7%
65,124
-1.4%
0.01%
-13.3%
Q1 2022$275,000
-18.6%
66,049
-6.3%
0.02%
-11.8%
Q4 2021$338,000
-8.2%
70,513
+2.3%
0.02%
-10.5%
Q3 2021$368,000
+49.0%
68,915
+43.1%
0.02%
+46.2%
Q2 2021$247,00048,1700.01%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$144,839,00011.40%
Eversept Partners, LP 4,755,480$32,004,3802.41%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$109,116,0001.27%
EAM Global Investors LLC 365,719$2,461,0000.68%
Signature Wealth Management Partners, LLC 87,666$590,0000.57%
Jackson Creek Investment Advisors LLC 221,043$1,488,0000.52%
Tranquilli Financial Advisor LLC 71,414$481,0000.39%
Hillsdale Investment Management Inc. 611,200$4,113,0000.34%
EAM Investors, LLC 259,873$1,749,0000.26%
HUSSMAN STRATEGIC ADVISORS, INC. 180,000$1,211,0000.25%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders